OVERVIEW

Participants will receive study medication for 28 days. There will be seven visits over approximately 10 weeks. This is an experimental treatment and is not yet approved in Australia.

ELIGIBILITY

• 18-65 years old
• Have a diagnosis of Chronic Plaque-Type Psoriasis for at least 6 months
• Be generally healthy
• Based in Sydney region

PRINCIPAL INVESTIGATOR

• Dr John Frew, Dermatologist

CONTACT US

Please contact Holdsworth House Research to register your interest:

Phone: 02 8038 1044

Email: studies@holdsworthhouse.com.au

Or enter your details below to request more information.